December 5, 2016
Takeda Pharmaceutical and California-based Lightstone Ventures have launched Cerevance, an R&D firm focusing on drug development for neurological and psychiatric disorders, the two companies said on December 2. Cerevance will take over facilities from Takeda’s Cambridge site in the UK,...read more